Potential oral capsule drug for neurological conditions a step closer
An Australian drug delivery technology, developed by Monash University researchers in partnership with PureTech Health plc (Nasdaq: PRTC, LSE: PRTC), has today released results from a multipart Phase 1 trial of the prodrug ...
Dec 21, 2022
0
4